Metraipolis › archive › dc_2bc27ebedb23

Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis — Europe PMC PMID:41709229

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41709229
DOI
10.1186/s13044-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-05T16:14:42.956Z
SHA-256 of the archived text
253ce5fcb0726d00de5b8afee07cd3714b4b881e2e26afb332a1f141e1319066
Stable URL of this page
https://metraipolis.com/documento/dc_2bc27ebedb23

How to cite

Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis — Europe PMC PMID:41709229 — Europe PMC (en), https://europepmc.org/article/MED/41709229 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bc27ebedb23 (Metraipolis archive dc_2bc27ebedb23, sha256 253ce5fcb0726d00de5b8afee07cd3714b4b881e2e26afb332a1f141e1319066)
BibTeX
@misc{dc2bc27ebedb23,
  title = {Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis — Europe PMC PMID:41709229},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41709229},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bc27ebedb23; sha256 253ce5fcb0726d00de5b8afee07cd3714b4b881e2e26afb332a1f141e1319066},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41709229. Agents can read the archived copy with the MCP tool read_document.